These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20851862)

  • 1. CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
    Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Cabes M; Lawrie CH; Moir D; Hatton C; Banham AH; Pulford K
    Haematologica; 2011 Jan; 96(1):78-86. PubMed ID: 20851862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
    Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Lawrie C; Moir D; Hatton C; Banham AH; Pulford K
    Br J Haematol; 2009 Aug; 146(4):396-407. PubMed ID: 19552722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.
    Liggins AP; Brown PJ; Asker K; Pulford K; Banham AH
    Br J Cancer; 2004 Jul; 91(1):141-9. PubMed ID: 15162151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
    Joseph-Pietras D; Gao Y; Zojer N; Ait-Tahar K; Banham AH; Pulford K; Rice J; Savelyeva N; Sahota SS
    Leukemia; 2010 Nov; 24(11):1951-9. PubMed ID: 20861911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma.
    Ait-Tahar K; Barnardo MC; Pulford K
    Cancer Res; 2007 Mar; 67(5):1898-901. PubMed ID: 17332315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of immunogenic PASD1 peptides against HLA-A*24:02 colorectal cancer.
    Soh JE; Abu N; Sagap I; Mazlan L; Yahaya A; Mustangin M; Khoo TS; Saidin S; Ishak M; Ab Mutalib NS; Jamal R
    Immunotherapy; 2019 Oct; 11(14):1205-1219. PubMed ID: 31478431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.
    Hardwick N; Buchan S; Ingram W; Khan G; Vittes G; Rice J; Pulford K; Mufti G; Stevenson F; Guinn BA
    Cancer Immun; 2013; 13():16. PubMed ID: 23882161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
    Kobayashi H; Wood M; Song Y; Appella E; Celis E
    Cancer Res; 2000 Sep; 60(18):5228-36. PubMed ID: 11016652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
    Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.
    Wong R; Lau R; Chang J; Kuus-Reichel T; Brichard V; Bruck C; Weber J
    Clin Cancer Res; 2004 Aug; 10(15):5004-13. PubMed ID: 15297401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy.
    de Rijke B; Fredrix H; Zoetbrood A; Scherpen F; Witteveen H; de Witte T; van de Wiel-Van Kemenade E; Dolstra H
    Blood; 2003 Oct; 102(8):2885-91. PubMed ID: 12842998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer testis antigen PASD1 expression and immunogenicity in human colorectal cancer and polyps.
    Sukor NF; Yahaya A; Sagap I; Jamal R; Johdi NA
    Turk J Biol; 2022; 46(5):361-374. PubMed ID: 37529004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal adhesion kinase as an immunotherapeutic target.
    Kobayashi H; Azumi M; Kimura Y; Sato K; Aoki N; Kimura S; Honma M; Iizuka H; Tateno M; Celis E
    Cancer Immunol Immunother; 2009 Jun; 58(6):931-40. PubMed ID: 18941742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
    Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma.
    Zhou Y; Zha J; Lin Z; Fang Z; Zeng H; Zhao J; Luo Y; Li Z; Xu B
    Exp Cell Res; 2018 Jan; 362(2):287-292. PubMed ID: 29174982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human CD4 helper T cell responses against Aurora kinase A.
    Kobayashi H; Azumi M; Hayashi S; Sato K; Aoki N; Kimura S; Kakizaki H; Nagato T; Harabuchi Y; Tateno M; Celis E
    Cancer Immunol Immunother; 2010 Jul; 59(7):1029-39. PubMed ID: 20182874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
    Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
    Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Four-Jointed Box 1 (FJX1)-Specific Peptides for Immunotherapy of Nasopharyngeal Carcinoma.
    Chai SJ; Yap YY; Foo YC; Yap LF; Ponniah S; Teo SH; Cheong SC; Patel V; Lim KP
    PLoS One; 2015; 10(11):e0130464. PubMed ID: 26536470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.